Agreed brooktrail- in a deeper dive this gets even more interesting. Roswell/ Puzanov/Mimivax vs UCLA/LL/nwbio. Survivin vs platform. On approval doorstep vs phase 2 completed…..for Roswell if you can’t beat’em then do the best you can to monetize your research because Survax is going to pull up lame. Voting Yes